CN106472680A - A kind of milk product - Google Patents

A kind of milk product Download PDF

Info

Publication number
CN106472680A
CN106472680A CN201510554139.5A CN201510554139A CN106472680A CN 106472680 A CN106472680 A CN 106472680A CN 201510554139 A CN201510554139 A CN 201510554139A CN 106472680 A CN106472680 A CN 106472680A
Authority
CN
China
Prior art keywords
extract
lactogenic
milk powder
milk
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510554139.5A
Other languages
Chinese (zh)
Inventor
钟虹光
易敏之
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangxi River Food Technology Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510554139.5A priority Critical patent/CN106472680A/en
Publication of CN106472680A publication Critical patent/CN106472680A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

It is an object of the present invention to provide a kind of new milk product, the present invention another object is that provides one kind to be available for postpartum breast milk hyposecretion or puerperal hypogalactia, puerpera's milk product that suitable puerperal, puerpera ate.Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract powder 1.5～3%；Docosahexenoic acid 2～5%；Conjugated linoleic acid glyceride 3～6%；Oligomeric galactose 3～6%；Oligofructose 0.33～0.67%；Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；Lactalbumin 3～20%；Lactose 3～6%；Vitamin 0.5～0.7%；Mineral 1.7～2%；Described lactogenic extract includes by weight percentage：One of Ungula Sus domestica or Radix Rumicis Japonici 2～100%, Carassius auratuss 2～100%, Cyprinus carpio 2～100%, Trichiurus haumela 2～100%, Squama Maniss 2～100%, Radix hemerocalis plicatae 2～100%, Semen sojae atricolor 2～100%, Medulla Tetrapanacis 2～100%, Retinervus Luffae Fructuss 2～100%, Fructus Chaenomeliss 2～100%, Semen arachidis hypogaeae 2～100%, Fructus Liquidambaris 2～100%, Stigma Maydis 2～100% or combination in any.

Description

A kind of milk product
Technical field
The present invention relates to a kind of milk product.
Background technology
At present, market there is the milk product of various formula, add various trophic factors, such as：The patent application of Application No. 201110359439.X adds the plant extract of multiple natural quality plant raw materials in the feed, fundamentally decrease that drink formulation milk powder causes gets angry, food stagnation and the symptom such as insufficiency of the spleen, glucose can also be added in described formula milk, fatty powder, maltodextrin and complex prebiotics, improve the digestive function of human body, formula milk refers on the basis of ordinary powdered milk, with the addition of trace element, vitamin, aminoacid or the composition of other " beneficial ", or change its casein/whey albumen, satisfied fatty acid/unsaturated fatty acid, Lactose, the content of the materials such as mineral, popularization with scientific and technical development and threpsology, formula milk product milk powder is increasingly liked by broad masses.
Breast milk is unique the most natural, the safest, the most complete natural food of baby development; it contains the nutritious and antibody needed for baby development; particularly promote the taurine of brain development, promote nucleotide, DHA of vision enhancing etc. that lactoferrin, prophylactic lysozyme, promotion organization that ferrum absorbs develop, these can effectively prevent and protect baby to avoid infecting and chronic disease generation, suppress intestinal pathogenic bacteria hypertrophy and help digest；Breast milk rich in proteins、Fat、Sugar、The nutrient substance such as mineral，And contain IgA、Macrophage、Lactoferrin、Lysozyme、Complement、Multiple nonspecific immunity material such as bifidus factor，There is the ability that protection baby resists microorganism infection，Therefore，It may be said that the breast milk of maturation to be baby development uniquely natural、The safest、Most complete natural food，And in recent years，Because puerpera age tends to increasing，In addition cesarean delivery rate rises，And trimester of pregnancy undernutrition、The factors such as spiritual hypertonicity，Puerperal hypogalactia is on the rise，Especially relatively conventional in city women，Development with modern society，By childbirth options、Health、Breast feeding confidence、Many impacts such as skill and breast problem，Increasing puerpera is perplexed by breast milk deficiency，Lactogenic also becomes most of puerpera's urgent problems,The purpose of the present invention is the feature for puerpera's puerperal hypogalactia，Design the formula milk product with lactogenic effect.
Content of the invention
It is an object of the present invention to provide a kind of new milk product, the present invention another object is that provides one kind to be available for postpartum breast milk hyposecretion or puerperal hypogalactia, puerpera's milk product that suitable puerperal, puerpera ate.
Milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract includes the extract of following raw materials：Ungula Sus domestica or Radix Rumicis Japonici, Carassius auratuss, Cyprinus carpio, Trichiurus haumela, Squama Maniss, Radix hemerocalis plicatae,
One of Semen sojae atricolor, Caulis Akebiae, Medulla Tetrapanacis, Retinervus Luffae Fructuss, Fructus Chaenomeliss, Semen arachidis hypogaeae, Fructus Liquidambaris, Stigma Maydis or combination in any.
Milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract includes by weight percentage：One of Ungula Sus domestica or Radix Rumicis Japonici 2～100%, Carassius auratuss 2～100%, Cyprinus carpio 2～100%, Trichiurus haumela 2～100%, Squama Maniss 2～100%, Radix hemerocalis plicatae 2～100%, Semen sojae atricolor 2～100%, Caulis Akebiae 2～100%, Medulla Tetrapanacis 2～100%, Retinervus Luffae Fructuss 2～100%, Fructus Chaenomeliss 2～100%, Semen arachidis hypogaeae 2～100%, Fructus Liquidambaris 2～100%, Stigma Maydis 2～100% or combination in any.
Milk product of the present invention it is preferable that by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract includes by weight percentage：One of Ungula Sus domestica or Radix Rumicis Japonici 15～90%, Carassius auratuss 15～90%, Cyprinus carpio 15～90%, Trichiurus haumela 15～90%, Squama Maniss 15～90%, Radix hemerocalis plicatae 10～85%, Semen sojae atricolor 10～85%, Medulla Tetrapanacis 10～85%, Caulis Akebiae 10～85%, Retinervus Luffae Fructuss 10～85%, Fructus Chaenomeliss 10～85%, Semen arachidis hypogaeae 10～85%, Fructus Liquidambaris 10～85%, Stigma Maydis 10～85% or combination in any.
Further preferably, milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract includes：One of Ungula Sus domestica or Radix Rumicis Japonici 50%, Carassius auratuss 50%, Cyprinus carpio 50%, Trichiurus haumela 50%, Squama Maniss 50%, Radix hemerocalis plicatae 50%, Semen sojae atricolor 50%, Medulla Tetrapanacis 50%, Retinervus Luffae Fructuss 50%, Fructus Chaenomeliss 50%, Semen arachidis hypogaeae 50%, Fructus Liquidambaris 50%, Caulis Akebiae 50%, Stigma Maydis 50% or combination in any.
Milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is Ungula Sus domestica extract or Radix Rumicis Japonici extract.
Milk product preferably of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is Ungula Sus domestica extract or Radix Rumicis Japonici extract.
Further preferably, milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is Ungula Sus domestica extract or Radix Rumicis Japonici extract.
Milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 2～95%；Radix hemerocalis plicatae 5～98%.
Milk product preferably of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 15～90%；Radix hemerocalis plicatae 10～85%.
Further preferably, milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is：Ungula Sus domestica or Radix Rumicis Japonici 50%；Radix hemerocalis plicatae 50%.
Milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is Radix hemerocalis plicatae extract.
Milk product preferably of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is Radix hemerocalis plicatae extract.
Further preferably, milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is Radix hemerocalis plicatae extract.
Milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is Medulla Tetrapanacis extract.
Milk product preferably of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is Medulla Tetrapanacis extract.
Further preferably, milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is Medulla Tetrapanacis extract.
Milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 3～95%；Radix hemerocalis plicatae 2～70%；Semen sojae atricolor 3～70%.
Milk product preferably of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 10～65%；Radix hemerocalis plicatae 8～60%；Semen sojae atricolor 8～60%.
Further preferably, milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is：Ungula Sus domestica or Radix Rumicis Japonici 40%；Radix hemerocalis plicatae 30%；Semen sojae atricolor 30%.
Milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 2～95%；Semen sojae atricolor 5～98%.
Milk product preferably of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 15～90%；Semen sojae atricolor 10～85%.
Further preferably, milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is：Ungula Sus domestica or Radix Rumicis Japonici 50%；Semen sojae atricolor 50%.
Milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 2～95%；Medulla Tetrapanacis 5～98%.
Milk product preferably of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 15～90%；Medulla Tetrapanacis 10～85%.
Further preferably, milk product of the present invention, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is：Ungula Sus domestica or Radix Rumicis Japonici 50%；Medulla Tetrapanacis 50%.
The above-mentioned vitamin of the present invention is Vitamin A Acetate, vitamin D3 (cholecalciferol), Vitamin E, vitamin C（Ascorbic acid）, vitamin B1（Thiamine hydrochloride）, vitamin B2（Riboflavin）, vitamin B6（Pyridoxine hydrochloride）, nicotinic acid, pantothenic acid（D-VB5 calcium）, Folic Acid, any one or a combination thereof in vitamin B12.
Above-mentioned mineral is Calcium Carbonate, calcium phosphate, ferrous sulfate, ferric phrophosphate, ferric ammonium citrate, magnesium sulfate, zinc sulfate, potassium chloride, any one or a combination thereof in taurine.
Wherein said oligomeric galactose（GOS）, oligofructose（Herba Cichorii is originated, FOS）Can also be substituted with one of dextrinosan, inulin or any mixing.
Described lactalbumin is concentrated lactoalbumin or whey powder.
Milk product of the present invention, adds or is added without appropriate vitamin, mineral and other adjuvants, processed makes various food, including liquid milk；Milk powder；Lactose；Milk slice；Fermentation milk；Condensed milk；Cheese；Other milk product forms such as processed cheese and butter, wherein liquid milk class mainly include pasteurization milk, sterilized milk, modulation breast, Yoghourt；Milk powder is whole milk powder, skimmed milk powder, half skimmed milk powder, modulation milk powder；Condensed milk includes evaporated milk, sweet condensed milk, modulation condensed milk etc..
Milk product of the present invention, liquid milk is one of pasteurization milk, sterilized milk, modulation breast, fermentation milk or its combination in any.
Milk product of the present invention, can make including one of liquid milk, milk powder, Lactose, milk slice or its combination in any.
Milk powder of the present invention is one of whole milk powder, skimmed milk powder, half skimmed milk powder, modulation milk powder or its combination in any.
Lactogenesis raw milk of the present invention, is the normal breast that no any composition of extrusion in healthy dairy stock breast changes.
Milk powder milk powder of the present invention, is with raw milk or raw Lac caprae seu ovis as raw material, processed makes full-cream, defat, half skimmed milk powder and one of modulation milk powder, cattle colostrums powder or its combination in any.
Ungula Sus domestica of the present invention, is that the Bauhinia variegata Linn of the Bauhinia variegata Linn porcine animals pig (Sus scrofa domestica Brisson) of porcine animals pig is used as medicine,《Sheng Nong's herbal classic》In i.e. on the books,《Compendium of Materia Medica》In have " dewclaw first ", " abnormal smells from the patient is salty flat, nontoxic, cures mainly five hemorrhoid latent heat in abdomen, erosion in acute appendicitis；Burn sootiness with Ramulus et Folium Bischofiae Javanicae, ward off all malignant boil " record,《Bencao Congxin》Point out:" pig dewclaw first, controls cold and heat phlegm dyspnea, and variola enters mesh, five hemorrhoid acute appendicitis ", Qi Taru《This warp》、《A thousand pieces of gold dietetic therapy》、《Renzhai Zhi Zhi Fang, Effective Recipes from Renzhai House》Medicinal to Ungula Sus domestica all on the books in each medical book of successive dynasties, Ungula Sus domestica is mild-natured, sweet in the mouth, salty, start with, Foot yangming Channel, there is the functions such as blood enriching and yin nourishing, lactogenesis, QI invigorating, be suitable for breast less, the disease such as carbuncle, sore, research has shown that, Ungula Sus domestica has antiinflammatory, hemostasis, improves the significantly pharmacologically active such as immunologic function.
Radix Rumicis Japonici of the present invention, is animal sheep（Caprinae）Four-footed, also known as poker, Radix Rumicis Japonici contains abundant collagenic protein, without cholesterol, can strengthen human body cell physiological metabolism, makes skin more high resilience and toughness, the aging of delaying skin；The effect of Radix Rumicis Japonici also has bone and muscle strengthening, has good dietary function to soreness of the waist and knees, asthenic body person, contributes to adolescent growth and develops and slow down the osteoporotic speed of middle-aged and elderly people, the nutritional labeling of Carnis caprae seu ovis is very abundant, its composition is in close proximity to human body, and easily digested absorbs《Compendium of Materia Medica》Once Carnis caprae seu ovis were mentioned in the same breath with Radix Ginseng, among the people Carnis caprae seu ovis are referred to as " Radix Codonopsis Cardiophyllae ", the nutritive value of Carnis caprae seu ovis is very high, not only has the feature of high protein, low fat, low cholesterol, and has good strengthening by means of tonics medical value；Hepar Caprae seu ovis, nature and flavor bitter cold, there is the effect of nourishing the liver to improve visual acuity；Ren caprae seu ovis, sweet in flavor and warm in property, have and tonify Qi of the kidney, fill up the effect of marrow.
Raw material Ungula Sus domestica of the present invention, can be replaced with the tellurium foot of the idol tellurium class animal such as poker or cattle tellurium；Can also be replaced with Unguis Sus domestica.
Carassius auratuss of the present invention, Carassius auratus , referred to asCrucian carp, be the one of which Fish that spoke fin net-rope Cypriniformes Cyprinidae crucian carp belongs to, flat property and sweet taste, enter stomach, kidney, have with middle qi-restoratives, except the feed of thin, stomach warming, invigorating middle warmer angry the effect of, Carassius auratuss are to weakness of the spleen and stomach, inappetence, dysentery；Hemoptysis of pulmonary tuberculosis；Edema, ascites expand；Toothache.
Radix hemerocalis plicatae (Hemerocallis fulva) of the present invention also known as Flos Hemerocallis, popular name Datlily, for Liliaceae herbaceos perennial, there is suppressing the hyperactive liver blood-nourishing, swelling diuretic, anti-inflammation, hemostasis, analgesia, lactogenesis, stomach invigorating and the function of calming the nerves, hepatitis can be treated, yellow subcutaneous ulcer, stool hematochezia, flu, dysentery, urinary tract infection, dizzy, tinnitus, cardiopalmus, lumbago, edema, hypogalactia, the various disease conditions such as arthralgia, Radix hemerocalis plicatae is nutritious, containing saccharide, protein, vitamin, inorganic salt and multiple aminoacid needed by human, chemical composition is broadly divided into terpenoid, lactams, Anthraquinones, Polyphenols, steroidal saponin, alkaloid etc., Hemerocallis citrina Baroni Lepidium high protein, low heat value, vegetable rich in vitamin and mineral.
Semen sojae atricolor of the present invention（Scientific name： Glycine max(L.) Merr）, it is generally called Semen Glyciness, the kernel seed coat colour according to Semen sojae atricolor and particle shape are divided into five classes：Semen Glyciness, green soybean, Semen sojae atricolor, other Semen sojae atricolor, feed soybean, sweet in the mouth, mild-natured, not warm not dry, energy invigorating spleen to remove dampness, there is QI invigorating profit skin, profit spleen is dry, removing food stagnancy dysentery, wide lower gas, profit large intestine, and disappear watery distension, controls the effect of toxic swelling.
Carassius auratuss of the present invention, Carassius auratus , referred to asCrucian carp, be the one of which Fish that spoke fin net-rope Cypriniformes Cyprinidae crucian carp belongs to, flat property and sweet taste, enter stomach, kidney, have with middle qi-restoratives, except the feed of thin, stomach warming, invigorating middle warmer angry the effect of, Carassius auratuss are to weakness of the spleen and stomach, inappetence, dysentery；Hemoptysis of pulmonary tuberculosis；Edema, ascites expand；Toothache.
Radix hemerocalis plicatae (Hemerocallis fulva) of the present invention also known as Flos Hemerocallis, popular name Datlily, for Liliaceae herbaceos perennial, there is suppressing the hyperactive liver blood-nourishing, swelling diuretic, anti-inflammation, hemostasis, analgesia, lactogenesis, stomach invigorating and the function of calming the nerves, hepatitis can be treated, yellow subcutaneous ulcer, stool hematochezia, flu, dysentery, urinary tract infection, dizzy, tinnitus, cardiopalmus, lumbago, edema, hypogalactia, the various disease conditions such as arthralgia, Radix hemerocalis plicatae is nutritious, containing saccharide, protein, vitamin, inorganic salt and multiple aminoacid needed by human, chemical composition is broadly divided into terpenoid, lactams, Anthraquinones, Polyphenols, steroidal saponin, alkaloid etc., Hemerocallis citrina Baroni Lepidium high protein, low heat value, vegetable rich in vitamin and mineral.
Semen sojae atricolor of the present invention（Scientific name： Glycine max(L.) Merr）, it is generally called Semen Glyciness, the kernel seed coat colour according to Semen sojae atricolor and particle shape are divided into five classes：Semen Glyciness, green soybean, Semen sojae atricolor, other Semen sojae atricolor, feed soybean, sweet in the mouth, mild-natured, not warm not dry, energy invigorating spleen to remove dampness, there is QI invigorating profit skin, profit spleen is dry, removing food stagnancy dysentery, wide lower gas, profit large intestine, and disappear watery distension, controls the effect of toxic swelling.
Medulla Tetrapanacis of the present invention, MEDULLA TETRAPANACI, is the stem pith that is dried of Araliaceae rice-paper plant, and property is sweet, light, is slightly cold, attaches to the lung and stomach meridians；Clearing away heat and promoting diuresis, stimulating milk secretion of ventilating；For damp and hot dark coloured urine, the puckery pain of gonorrhea, edema oliguria, agalactia.
Retinervus Luffae Fructuss Vegetable Sponge of Luffa of the present invention, is the vascular bundle of the mature fruit of cucurbitaceous plant Fructus Luffae or Guangdong Fructus Luffae.Also known as sky trailing plants muscle（《Arteries and veins is controlled because of card》）, Fructus Luffae shell（《Classification is herbal》）, melon network, wadding melon pulp（《Guangzhou flora》）, sky sieve line（《Medical material compilation of data》）, vegetable sponge（《Jiangsu Province's vegetable drug will》）, chalina（《Hebei medical material》）, Hypericum perforatum L.（《Hunan medicine will》）, Fructus Luffae cloth（《Chinese herbal medicine is commonly used in Sichuan》）, sweet in the mouth, cool in nature.Return lung, liver, stomach, have dredge the meridian passage, removing toxic substances and promoting subsidence of swelling inducing diuresis to remove edema, effect of hemostasis；Cure mainly distending pain in the chest and hypochondrium, rheumatic arthralgia, muscle arteries and veins contraction, woman's amenorrhea, galactostasiss, phlegm-heat cough, pyretic toxicity carbuncle, anal fistula, edema, dysuria, have blood in stool, metrorrhagia.
Cyprinus carpio Cyprinus carpio of the present invention, sweet in the mouth；Mild-natured, nontoxic, returns spleen；Kidney；Stomach；Gallbladder meridian；There is invigorating the spleen and regulating the stomach；The diuretic therapeutic method to keep the adverse QI flowing downwards；Lactogenesis；Antiabortive effect.
Trichiurus haumela Regalecus glesne of the present invention, warm in nature, sweet in the mouth, salty, returns spleen, stomach；There is qi-restoratives；Removing toxic substances；Hemostasia effect.Cure mainly body void after being ill；Hypogalactia in puerperal；Furuncle carbuncle；Traumatic hemorrhage.
Fructus Chaenomeliss Fructus Chaenomelis of the present invention, sour in the mouth, warm in nature；Return liver, spleen channel；【Indication】Relaxing muscles and tendons and activating QI and blood in the collateral, removing dampness to restore normal function of the stomach.For rheumatic arthralgia, muscle arteries and veins contraction, tinea pedis swells and ache, convulsion of vomiting and diarrhoea.
Semen arachidis hypogaeae of the present invention, Arachis hypogaea, sweet in the mouth, flat, returns spleen, lung meridian.There is lung moistening, stomach function regulating, spleen reinforcing.For hypertension, hyperlipidemia, coronary heart disease, arteriosclerosis, hypogalactia of lying-in woman, malnutrition, inappetence.
Squama Maniss Manis pentadactyla of the present invention, salty in the mouth；Cold nature.Return liver；Stomach；There is blood circulation promoting and dispersing pathogen accumulation；Stimulate the menstrual flow stimulating milk secretion；Anti-stain in solid.For blood stasis is through closing；Lump in the abdomen；Rheumatic arthralgia；Agalactia；Carbuncle；Scrofula；
Fructus Liquidambaris of the present invention are Hamamelidaceae Plants Chinese sweet gumLiquidambar formosanaThe drying and ripening infructescence of Hance, bitter in the mouth, mild-natured.Return liver and kidney channel.For arthralgia, numb spasm, oedema turgor, breast is few, amenorrhea.
Stigma Maydis of the present invention, are style and the stigma of grass Semen Maydiss Zea mays L., sweet in the mouth, light, mild-natured.Return bladder, liver, gallbladder meridian.There is inducing diuresis to remove edema;Effect of liver heat removing function of gallbladder promoting, main edema, dribbling urination, jaundice, cholecystitis, cholelithiasis, hypertension, diabetes, galactostasiss.
Caulis Akebiae Caulis Akebiae of the present invention；Bitter in the mouth, cold in nature；Enter the heart, lung, bladder warp；Pathogenic fire purging row water, promoting blood circulation, for hot urination, stranguria with turbid discharge, edema, irritable feverish sensation in the chest, larynx numbness pharyngalgia, inflexible pain all over, women's amenorrhea, galactostasiss.
Oligomeric galactose of the present invention is GOS；Oligofructose is FOS.It is a kind of dietary supplement, mainly include various oligosaccharide kind materials（Oligosaccharides）Or title oligosaccharide（It is made up of 2～10 molecule monosaccharide）, it is functional oligose.
DHA of the present invention, docosahexenoic acid, it is commonly called as NAOHUANGJIN, be a kind of unsaturated fatty acid very important to human body, belong toωImportant member in -3 unsaturated fatty acid families, DHA is nervous system cell growth and a kind of main component maintaining, it is the important composition composition of brain and retina, in human brain cortex, content is up to 20%, in eye retina, proportion is maximum, account for 50%, therefore, most important to tire infant intelligence and visual acuity.
The invention still further relates to containing the application in preparation lactogenic product in the milk product in the weight percentage ranges of above-mentioned each composition.
Essence for a better understanding of the present invention, the milk product made with each proportioning raw materials of milk powder of the present invention below：Lactogenic extract；Docosahexenoic acid (DHA) powder；Conjugated linoleic acid glyceride；Oligomeric galactose（GOS）；Oligofructose；Milk powder；Lactalbumin；Lactose；Vitamin；Mineral；Wherein said lactogenic extract is Ungula Sus domestica or Radix Rumicis Japonici, Radix hemerocalis plicatae, Semen sojae atricolor, the combination in any of Medulla Tetrapanacis, and the galgctogogue action of inventive formulation milk powder is described by zoopery and result；Similarly, or also Carassius auratuss, Cyprinus carpio, Trichiurus haumela, Squama Maniss, Retinervus Luffae Fructuss, Fructus Chaenomeliss, Semen arachidis hypogaeae, Fructus Liquidambaris, the formula milk of Stigma Maydis composition can be added in formula also to can reach same pharmacological action.
First, the milk product that composition of raw materials of the present invention is made, feedstock composition 1（Milk powder；Ungula Sus domestica；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, the milk product prepared as described in Example 5, prove, to puerperal hypogalactia rat, there is galgctogogue action through animal experiment, its detailed description is as follows：
1. Materials and methods
1.1 Sample source：Tested material is compositionss 1（Milk powder；Ungula Sus domestica；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, the milk product prepared as described in Example 5, provided by Jiangzhong Pharmaceutical Co., Ltd., clinical people's consumption is：81g/ days, use at twice.
Laboratory animal：SD rat, body weight 220～260g, provided by Jiangxi College of Traditional Chinese Medicine Experimental Animal Center, SCXK (Jiangxi) 2009-0001.
Main agents：Levodopa injection (Fuda Pharmaceutical Co., Ltd., Shanghai, lot number 101015),125I lactotropin medicine box (Tianjin Depew biotechnology and medical product company limited, lot number 110523).
Key instrument：Table-type high-speed refrigerated centrifuge（Thermo, the U.S.）；Electronic balance (1/10,1/100,1/10000, Mei Tele company)；Gilson p-type pipettor（Gilson, France）；Intelligence is put and is exempted from measuring instrument (Shanghai nuclear research institute day ring instrument one factory).
Experimental technique
2.1 Animal packet：Male rat is pressed 1 with without female rats that are pregnant, producing：4 ratios are raised with cage, and natural mating is become pregnant, and screen pregnant Mus using pallet the moon bolt inspection technique, Mus single cage of becoming pregnant is raised and is used for testing.Before and after taking the farrowing time, as experimentation object, every nest filial mice is adjusted to 8 to 50 dams less than 24 h for the difference.50 dams are randomly divided into Normal group, model control group, compositionss 1 high dose group, compositionss 1 middle dose group, compositionss 1 low dose group, every group of l0 dams by body weight.
Animal model：In addition to Normal group, remaining group rat, from childbirth the 2nd day, is sooner or later respectively once given dams lumbar injection levodopa 5mg/kg, continuously injects 10d, replicate puerperal hypogalactia rat model.
Administration：From childbirth the 2nd day, Normal group, model control group daily distilled water gavage, compositionss 1 low dose group (4.05g/kg), compositionss 1 middle dose group (8.1g/kg), compositionss 1 high dose group (16.2 g/kg) are respectively with respective dosage gavage, 20ml/kg, each 1 time of gavage respective concentration of upper and lower noon tested material daily, successive administration 10 d.The equal normal diet of each group animal is drunk water.
Testing index：During daily morning 8, electronic scale (degree of accuracy is 0.1g) claims filial mice weight, the difference of the 1st day body weight of every every daily weight of nest filial mice and childbirth is the value added of every nest filial mice body weight, and value added is filial mice weight gain divided by the value of the 1st day body weight gained of childbirth.Be born the 2nd day and start, filial mice and dams are divided cage, after 7 h, weigh after every nest filial mice body weight the same cage with dams, allow dams feed breast, after 1 h, again weigh to every nest filial mice, using suckling forebody-afterbody method of double differences value as dams 8 h lactation amount.Measure 1 time daily, continuous 9 d.5 groups of female rat the 4th, 7,10 day early morning tail veins after childbirth take blood, and centrifugation takes supernatant, measures serum prolactin (PRL) level.
Statistical method：Experimental data with Represent, using one factor analysis of variance, compare the difference between each group,It is judged as that difference has significance,It is judged as that difference has pole significance.
Result
3.1 Compositionss 1 Impact to the hypogalactia dams lactation amount of levodopaThe results are shown in Table 1.Compared with blank group rat, model group rats the 4th, 7,10 days 8h lactation amounts after childbirth significantly reduce.Compare with model control group, the basic, normal, high dosage group rat of compositionss 1 the 4th, 7,10 days 8h lactation amounts after childbirth substantially increase.Prompting combination thing 1 can increase the hypogalactia dams lactation amount of levodopa.
Compositionss 1 Impact to filial mice body weight The results are shown in Table 2.Compared with blank group rat, model group filial mice the 4th, 7,10 days weight gain after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group filial mice of compositionss 1 the 4th, 7,10 days weight gain after childbirth substantially increase.Prompting combination thing 1 can promote filial mice body weight increase.
Compositionss 1 Impact to rat prolactin secretion age of sucking The results are shown in Table 3.Compared with blank group rat, model group dams the 4th, 7,10 days Serum Prolactin In Patients after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group dams of compositionss 1 the 4th, 7,10 days Serum Prolactin In Patients after childbirth substantially increase.Prompting combination thing 1 can increase the secretion of dams lactotropin.
Conclusion :
Animal experiment study shows：Compositionss 1 can increase the hypogalactia dams lactation amount of levodopa, promotes filial mice body weight increase, increases the secretion of dams lactotropin, and prompting combination thing 1 plays the role of lactogenic.
2nd, the milk product that composition of raw materials of the present invention is made, feedstock composition 2（Milk powder；Ungula Sus domestica；Radix hemerocalis plicatae；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, the milk product prepared as described in Example 10, prove, to puerperal hypogalactia rat, there is galgctogogue action through animal experiment, its detailed description is as follows：
1. Materials and methods
1.1 Sample source：Tested material is compositionss 2（Milk powder；Ungula Sus domestica；Radix hemerocalis plicatae；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, the milk product prepared as described in Example 10, provided by Jiangzhong Pharmaceutical Co., Ltd., clinical people's consumption is：81g/ days, use at twice.
Laboratory animal：SD rat, body weight 220～260g, provided by Jiangxi College of Traditional Chinese Medicine Experimental Animal Center, SCXK (Jiangxi) 2009-0001.
Main agents：Levodopa injection (Fuda Pharmaceutical Co., Ltd., Shanghai, lot number 101015),125I lactotropin medicine box (Tianjin Depew biotechnology and medical product company limited, lot number 110523).
Key instrument：Table-type high-speed refrigerated centrifuge（Thermo, the U.S.）；Electronic balance (1/10,1/100,1/10000, Mei Tele company)；Gilson p-type pipettor（Gilson, France）；Intelligence is put and is exempted from measuring instrument (Shanghai nuclear research institute day ring instrument one factory).
Experimental technique
2.1 Animal packet：Male rat is pressed 1 with without female rats that are pregnant, producing：4 ratios are raised with cage, and natural mating is become pregnant, and screen pregnant Mus using pallet the moon bolt inspection technique, Mus single cage of becoming pregnant is raised and is used for testing.Before and after taking the farrowing time, as experimentation object, every nest filial mice is adjusted to 8 to 50 dams less than 24 h for the difference.50 dams are randomly divided into Normal group, model control group, compositionss 2 high dose group, compositionss 2 middle dose group, compositionss 2 low dose group, every group of l0 dams by body weight.
Animal model：In addition to Normal group, remaining group rat, from childbirth the 2nd day, is sooner or later respectively once given dams lumbar injection levodopa 5mg/kg, continuously injects 10d, replicate puerperal hypogalactia rat model.
Administration：From childbirth the 2nd day, Normal group, model control group daily distilled water gavage, compositionss 2 low dose group (4.05g/kg), compositionss 2 middle dose group (8.1g/kg), compositionss 2 high dose group (16.2 g/kg) are respectively with respective dosage gavage, 20ml/kg, each 1 time of gavage respective concentration of upper and lower noon tested material daily, successive administration 10 d.The equal normal diet of each group animal is drunk water.
Testing index：During daily morning 8, electronic scale (degree of accuracy is 0.1g) claims filial mice weight, the difference of the 1st day body weight of every every daily weight of nest filial mice and childbirth is the value added of every nest filial mice body weight, and value added is filial mice weight gain divided by the value of the 1st day body weight gained of childbirth.Be born the 2nd day and start, filial mice and dams are divided cage, after 7 h, weigh after every nest filial mice body weight the same cage with dams, allow dams feed breast, after 1 h, again weigh to every nest filial mice, using suckling forebody-afterbody method of double differences value as dams 8 h lactation amount.Measure 1 time daily, continuous 9 d.5 groups of female rat the 4th, 7,10 day early morning tail veins after childbirth take blood, and centrifugation takes supernatant, measures serum prolactin (PRL) level.
Statistical method：Experimental data withRepresent, using one factor analysis of variance, compare the difference between each group,It is judged as that difference has significance,It is judged as that difference has pole significance.
Result
3.1 Compositionss 2 Impact to the hypogalactia dams lactation amount of levodopaThe results are shown in Table 1.Compared with blank group rat, model group rats the 4th, 7,10 days 8h lactation amounts after childbirth significantly reduce.Compare with model control group, the basic, normal, high dosage group rat of compositionss 2 the 4th, 7,10 days 8h lactation amounts after childbirth substantially increase.Prompting combination thing 2 can increase the hypogalactia dams lactation amount of levodopa.
Compositionss 2 Impact to filial mice body weight The results are shown in Table 2.Compared with blank group rat, model group filial mice the 4th, 7,10 days weight gain after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group filial mice of compositionss 2 the 4th, 7,10 days weight gain after childbirth substantially increase.Prompting combination thing 2 can promote filial mice body weight increase.
Compositionss 2 Impact to rat prolactin secretion age of sucking The results are shown in Table 3.Compared with blank group rat, model group dams the 4th, 7,10 days Serum Prolactin In Patients after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group dams of compositionss 2 the 4th, 7,10 days Serum Prolactin In Patients after childbirth substantially increase.Prompting combination thing 2 can increase the secretion of dams lactotropin.
Conclusion :
Animal experiment study shows：Compositionss 2 can increase the hypogalactia dams lactation amount of levodopa, promotes filial mice body weight increase, increases the secretion of dams lactotropin, and prompting combination thing 2 plays the role of lactogenic.
3rd, the milk product that composition of raw materials of the present invention is made, feedstock composition 3（Milk powder；Ungula Sus domestica；Semen sojae atricolor；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, by the milk product of the method preparation of embodiment 45, prove, to puerperal hypogalactia rat, there is galgctogogue action through animal experiment, its detailed description is as follows：
1. Materials and methods
1.1 Sample source：Tested material is compositionss 3（Milk powder；Ungula Sus domestica；Semen sojae atricolor；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, by the milk product of the method preparation of embodiment 45；There is provided by Jiangzhong Pharmaceutical Co., Ltd., clinical people's consumption is：81g/ days, use at twice.
Laboratory animal：SD rat, body weight 220～260g, provided by Jiangxi College of Traditional Chinese Medicine Experimental Animal Center, SCXK (Jiangxi) 2009-0001.
Main agents：Levodopa injection (Fuda Pharmaceutical Co., Ltd., Shanghai, lot number 101015),125I lactotropin medicine box (Tianjin Depew biotechnology and medical product company limited, lot number 110523).
Key instrument：Table-type high-speed refrigerated centrifuge（Thermo, the U.S.）；Electronic balance (1/10,1/100,1/10000, Mei Tele company)；Gilson p-type pipettor（Gilson, France）；Intelligence is put and is exempted from measuring instrument (Shanghai nuclear research institute day ring instrument one factory).
Experimental technique
2.1 Animal packet：Male rat is pressed 1 with without female rats that are pregnant, producing：4 ratios are raised with cage, and natural mating is become pregnant, and screen pregnant Mus using pallet the moon bolt inspection technique, Mus single cage of becoming pregnant is raised and is used for testing.Before and after taking the farrowing time, as experimentation object, every nest filial mice is adjusted to 8 to 50 dams less than 24 h for the difference.50 dams are randomly divided into Normal group, model control group, compositionss 3 high dose group, compositionss 3 middle dose group, compositionss 3 low dose group, every group of l0 dams by body weight.
Animal model：In addition to Normal group, remaining group rat, from childbirth the 2nd day, is sooner or later respectively once given dams lumbar injection levodopa 5mg/kg, continuously injects 10d, replicate puerperal hypogalactia rat model.
Administration：From childbirth the 2nd day, Normal group, model control group daily distilled water gavage, compositionss 3 low dose group (4.05g/kg), compositionss 3 middle dose group (8.1g/kg), compositionss 3 high dose group (16.2 g/kg) are respectively with respective dosage gavage, 20ml/kg, each 1 time of gavage respective concentration of upper and lower noon tested material daily, successive administration 10 d.The equal normal diet of each group animal is drunk water.
Testing index：During daily morning 8, electronic scale (degree of accuracy is 0.1g) claims filial mice weight, the difference of the 1st day body weight of every every daily weight of nest filial mice and childbirth is the value added of every nest filial mice body weight, and value added is filial mice weight gain divided by the value of the 1st day body weight gained of childbirth.Be born the 2nd day and start, filial mice and dams are divided cage, after 7 h, weigh after every nest filial mice body weight the same cage with dams, allow dams feed breast, after 1 h, again weigh to every nest filial mice, using suckling forebody-afterbody method of double differences value as dams 8 h lactation amount.Measure 1 time daily, continuous 9 d.5 groups of female rat the 4th, 7,10 day early morning tail veins after childbirth take blood, and centrifugation takes supernatant, measures serum prolactin (PRL) level.
Statistical method：Experimental data withRepresent, using one factor analysis of variance, compare the difference between each group,It is judged as that difference has significance,It is judged as that difference has pole significance.
Result
3.1 Compositionss 3 Impact to the hypogalactia dams lactation amount of levodopaThe results are shown in Table 1.Compared with blank group rat, model group rats the 4th, 7,10 days 8h lactation amounts after childbirth significantly reduce.Compare with model control group, the basic, normal, high dosage group rat of compositionss 3 the 4th, 7,10 days 8h lactation amounts after childbirth substantially increase.Prompting combination thing 3 can increase the hypogalactia dams lactation amount of levodopa.
Compositionss 3 Impact to filial mice body weight The results are shown in Table 2.Compared with blank group rat, model group filial mice the 4th, 7,10 days weight gain after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group filial mice of compositionss 3 the 4th, 7,10 days weight gain after childbirth substantially increase.Prompting combination thing 3 can promote filial mice body weight increase.
Compositionss 3 Impact to rat prolactin secretion age of sucking The results are shown in Table 3.Compared with blank group rat, model group dams the 4th, 7,10 days Serum Prolactin In Patients after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group dams of compositionss 3 the 4th, 7,10 days Serum Prolactin In Patients after childbirth substantially increase.Prompting combination thing 3 can increase the secretion of dams lactotropin.
Conclusion :
Animal experiment study shows：Compositionss 3 can increase the hypogalactia dams lactation amount of levodopa, promotes filial mice body weight increase, increases the secretion of dams lactotropin, and prompting combination thing 3 plays the role of lactogenic.
4th, the milk product that composition of raw materials of the present invention is made, feedstock composition 4（Milk powder；Ungula Sus domestica；Medulla Tetrapanacis；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, by the milk product of the method preparation of embodiment 34, prove, to puerperal hypogalactia rat, there is galgctogogue action through animal experiment, its detailed description is as follows：
1. Materials and methods
1.1 Sample source：Tested material is compositionss 4（Milk powder；Ungula Sus domestica；Medulla Tetrapanacis；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, by the milk product of the method preparation of embodiment 34, provided by Jiangzhong Pharmaceutical Co., Ltd., clinical people's consumption is：81g/ days, use at twice.
Laboratory animal：SD rat, body weight 220～260g, provided by Jiangxi College of Traditional Chinese Medicine Experimental Animal Center, SCXK (Jiangxi) 2009-0001.
Main agents：Levodopa injection (Fuda Pharmaceutical Co., Ltd., Shanghai, lot number 101015),125I lactotropin medicine box (Tianjin Depew biotechnology and medical product company limited, lot number 110523).
Key instrument：Table-type high-speed refrigerated centrifuge（Thermo, the U.S.）；Electronic balance (1/10,1/100,1/10000, Mei Tele company)；Gilson p-type pipettor（Gilson, France）；Intelligence is put and is exempted from measuring instrument (Shanghai nuclear research institute day ring instrument one factory).
Experimental technique
2.1 Animal packet：Male rat is pressed 1 with without female rats that are pregnant, producing：4 ratios are raised with cage, and natural mating is become pregnant, and screen pregnant Mus using pallet the moon bolt inspection technique, Mus single cage of becoming pregnant is raised and is used for testing.Before and after taking the farrowing time, as experimentation object, every nest filial mice is adjusted to 8 to 50 dams less than 24 h for the difference.50 dams are randomly divided into Normal group, model control group, compositionss 4 high dose group, compositionss 4 middle dose group, compositionss 4 low dose group, every group of l0 dams by body weight.
Animal model：In addition to Normal group, remaining group rat, from childbirth the 2nd day, is sooner or later respectively once given dams lumbar injection levodopa 5mg/kg, continuously injects 10d, replicate puerperal hypogalactia rat model.
Administration：From childbirth the 2nd day, Normal group, model control group daily distilled water gavage, compositionss 4 low dose group (4.05g/kg), compositionss 4 middle dose group (8.1g/kg), compositionss 4 high dose group (16.2 g/kg) are respectively with respective dosage gavage, 20ml/kg, each 1 time of gavage respective concentration of upper and lower noon tested material daily, successive administration 10 d.The equal normal diet of each group animal is drunk water.
Testing index：During daily morning 8, electronic scale (degree of accuracy is 0.1g) claims filial mice weight, the difference of the 1st day body weight of every every daily weight of nest filial mice and childbirth is the value added of every nest filial mice body weight, and value added is filial mice weight gain divided by the value of the 1st day body weight gained of childbirth.Be born the 2nd day and start, filial mice and dams are divided cage, after 7 h, weigh after every nest filial mice body weight the same cage with dams, allow dams feed breast, after 1 h, again weigh to every nest filial mice, using suckling forebody-afterbody method of double differences value as dams 8 h lactation amount.Measure 1 time daily, continuous 9 d.5 groups of female rat the 4th, 7,10 day early morning tail veins after childbirth take blood, and centrifugation takes supernatant, measures serum prolactin (PRL) level.
Statistical method：Experimental data with` represents, using one factor analysis of variance, compares the difference between each group,It is judged as that difference has significance,It is judged as that difference has pole significance.
Result
3.1 Compositionss 4 Impact to the hypogalactia dams lactation amount of levodopaThe results are shown in Table 1.Compared with blank group rat, model group rats the 4th, 7,10 days 8h lactation amounts after childbirth significantly reduce.Compare with model control group, the basic, normal, high dosage group rat of compositionss 4 the 4th, 7,10 days 8h lactation amounts after childbirth substantially increase.Prompting combination thing 4 can increase the hypogalactia dams lactation amount of levodopa.
Compositionss 4 Impact to filial mice body weight The results are shown in Table 2.Compared with blank group rat, model group filial mice the 4th, 7,10 days weight gain after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group filial mice of compositionss 4 the 4th, 7,10 days weight gain after childbirth substantially increase.Prompting combination thing 4 can promote filial mice body weight increase.
Compositionss 4 Impact to rat prolactin secretion age of sucking The results are shown in Table 3.Compared with blank group rat, model group dams the 4th, 7,10 days Serum Prolactin In Patients after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group dams of compositionss 4 the 4th, 7,10 days Serum Prolactin In Patients after childbirth substantially increase.Prompting combination thing 4 can increase the secretion of dams lactotropin.
Conclusion :
Animal experiment study shows：Compositionss 4 can increase the hypogalactia dams lactation amount of levodopa, promotes filial mice body weight increase, increases the secretion of dams lactotropin, and prompting combination thing 4 plays the role of lactogenic.
5th, the milk product that composition of raw materials of the present invention is made, material combination compositions 5（Milk powder；Ungula Sus domestica；Radix hemerocalis plicatae；Semen sojae atricolor；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, by the milk product of the method preparation of embodiment 25, prove, to puerperal hypogalactia rat, there is galgctogogue action through animal experiment, its detailed description is as follows：
1. Materials and methods
1.1 Sample source：Tested material is compositionss 5（Milk powder；Ungula Sus domestica；Radix hemerocalis plicatae；Semen sojae atricolor；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, by the milk product of the method preparation of embodiment 25, provided by Jiangzhong Pharmaceutical Co., Ltd., clinical people's consumption is：81g/ days, use at twice.
Laboratory animal：SD rat, body weight 220～260g, provided by Jiangxi College of Traditional Chinese Medicine Experimental Animal Center, SCXK (Jiangxi) 2009-0001.
Main agents：Levodopa injection (Fuda Pharmaceutical Co., Ltd., Shanghai, lot number 101015),125I lactotropin medicine box (Tianjin Depew biotechnology and medical product company limited, lot number 110523).
Key instrument：Table-type high-speed refrigerated centrifuge（Thermo, the U.S.）；Electronic balance (1/10,1/100,1/10000, Mei Tele company)；Gilson p-type pipettor（Gilson, France）；Intelligence is put and is exempted from measuring instrument (Shanghai nuclear research institute day ring instrument one factory).
Experimental technique
2.1 Animal packet：Male rat is pressed 1 with without female rats that are pregnant, producing：4 ratios are raised with cage, and natural mating is become pregnant, and screen pregnant Mus using pallet the moon bolt inspection technique, Mus single cage of becoming pregnant is raised and is used for testing.Before and after taking the farrowing time, as experimentation object, every nest filial mice is adjusted to 8 to 50 dams less than 24 h for the difference.50 dams are randomly divided into Normal group, model control group, compositionss 5 high dose group, compositionss 5 middle dose group, compositionss 5 low dose group, every group of l0 dams by body weight.
Animal model：In addition to Normal group, remaining group rat, from childbirth the 2nd day, is sooner or later respectively once given dams lumbar injection levodopa 5mg/kg, continuously injects 10d, replicate puerperal hypogalactia rat model.
Administration：From childbirth the 2nd day, Normal group, model control group daily distilled water gavage, compositionss 5 low dose group (4.05g/kg), compositionss 5 middle dose group (8.1g/kg), compositionss 5 high dose group (16.2 g/kg) are respectively with respective dosage gavage, 20ml/kg, each 1 time of gavage respective concentration of upper and lower noon tested material daily, successive administration 10 d.The equal normal diet of each group animal is drunk water.
Testing index：During daily morning 8, electronic scale (degree of accuracy is 0.1g) claims filial mice weight, the difference of the 1st day body weight of every every daily weight of nest filial mice and childbirth is the value added of every nest filial mice body weight, and value added is filial mice weight gain divided by the value of the 1st day body weight gained of childbirth.Be born the 2nd day and start, filial mice and dams are divided cage, after 7 h, weigh after every nest filial mice body weight the same cage with dams, allow dams feed breast, after 1 h, again weigh to every nest filial mice, using suckling forebody-afterbody method of double differences value as dams 8 h lactation amount.Measure 1 time daily, continuous 9 d.5 groups of female rat the 4th, 7,10 day early morning tail veins after childbirth take blood, and centrifugation takes supernatant, measures serum prolactin (PRL) level.
Statistical method：Experimental data withRepresent, using one factor analysis of variance, compare the difference between each group,It is judged as that difference has significance,It is judged as that difference has pole significance.
Result
3.1 Compositionss 5 Impact to the hypogalactia dams lactation amount of levodopaThe results are shown in Table 1.Compared with blank group rat, model group rats the 4th, 7,10 days 8h lactation amounts after childbirth significantly reduce.Compare with model control group, the basic, normal, high dosage group rat of compositionss 5 the 4th, 7,10 days 8h lactation amounts after childbirth substantially increase.Prompting combination thing 5 can increase the hypogalactia dams lactation amount of levodopa.
3.2 Compositionss 5 Impact to filial mice body weightThe results are shown in Table 2.Compared with blank group rat, model group filial mice the 4th, 7,10 days weight gain after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group filial mice of compositionss 5 the 4th, 7,10 days weight gain after childbirth substantially increase.Prompting combination thing 5 can promote filial mice body weight increase.
Compositionss 5 Impact to rat prolactin secretion age of sucking The results are shown in Table 3.Compared with blank group rat, model group dams the 4th, 7,10 days Serum Prolactin In Patients after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group dams of compositionss 5 the 4th, 7,10 days Serum Prolactin In Patients after childbirth substantially increase.Prompting combination thing 5 can increase the secretion of dams lactotropin.
Conclusion :
Animal experiment study shows：Compositionss 5 can increase the hypogalactia dams lactation amount of levodopa, promotes filial mice body weight increase, increases the secretion of dams lactotropin, and prompting combination thing 5 plays the role of lactogenic.
6th, the milk product that composition of raw materials of the present invention is made, feedstock composition 6（Milk powder；Medulla Tetrapanacis；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, the milk product prepared as described in Example 16, prove, to puerperal hypogalactia rat, there is galgctogogue action through animal experiment, its detailed description is as follows：
1. Materials and methods
1.1 Sample source：Tested material is compositionss 6（Milk powder；Medulla Tetrapanacis；Docosahexenoic acid；Conjugated linoleic acid glyceride；Oligomeric galactose；Oligofructose；Lactalbumin；Lactose；Vitamin；Mineral）, the milk product prepared as described in Example 16, provided by Jiangzhong Pharmaceutical Co., Ltd., clinical people's consumption is：81g/ days, use at twice.
Laboratory animal：SD rat, body weight 220～260g, provided by Jiangxi College of Traditional Chinese Medicine Experimental Animal Center, SCXK (Jiangxi) 2009-0001.
Main agents：Levodopa injection (Fuda Pharmaceutical Co., Ltd., Shanghai, lot number 101015),125I lactotropin medicine box (Tianjin Depew biotechnology and medical product company limited, lot number 110523).
Key instrument：Table-type high-speed refrigerated centrifuge（Thermo, the U.S.）；Electronic balance (1/10,1/100,1/10000, Mei Tele company)；Gilson p-type pipettor（Gilson, France）；Intelligence is put and is exempted from measuring instrument (Shanghai nuclear research institute day ring instrument one factory).
Experimental technique
2.1 Animal packet：Male rat is pressed 1 with without female rats that are pregnant, producing：4 ratios are raised with cage, and natural mating is become pregnant, and screen pregnant Mus using pallet the moon bolt inspection technique, Mus single cage of becoming pregnant is raised and is used for testing.Before and after taking the farrowing time, as experimentation object, every nest filial mice is adjusted to 8 to 50 dams less than 24 h for the difference.50 dams are randomly divided into Normal group, model control group, compositionss 6 high dose group, compositionss 6 middle dose group, compositionss 6 low dose group, every group of l0 dams by body weight.
Animal model：In addition to Normal group, remaining group rat, from childbirth the 2nd day, is sooner or later respectively once given dams lumbar injection levodopa 5mg/kg, continuously injects 10d, replicate puerperal hypogalactia rat model.
Administration：From childbirth the 2nd day, Normal group, model control group daily distilled water gavage, compositionss 6 low dose group (4.05g/kg), compositionss 6 middle dose group (8.1g/kg), compositionss 6 high dose group (16.2 g/kg) are respectively with respective dosage gavage, 20ml/kg, each 1 time of gavage respective concentration of upper and lower noon tested material daily, successive administration 10 d.The equal normal diet of each group animal is drunk water.
Testing index：During daily morning 8, electronic scale (degree of accuracy is 0.1g) claims filial mice weight, the difference of the 1st day body weight of every every daily weight of nest filial mice and childbirth is the value added of every nest filial mice body weight, and value added is filial mice weight gain divided by the value of the 1st day body weight gained of childbirth.Be born the 2nd day and start, filial mice and dams are divided cage, after 7 h, weigh after every nest filial mice body weight the same cage with dams, allow dams feed breast, after 1 h, again weigh to every nest filial mice, using suckling forebody-afterbody method of double differences value as dams 8 h lactation amount.Measure 1 time daily, continuous 9 d.5 groups of female rat the 4th, 7,10 day early morning tail veins after childbirth take blood, and centrifugation takes supernatant, measures serum prolactin (PRL) level.
Statistical method：Experimental data is with `Represent, using one factor analysis of variance, compare the difference between each group,It is judged as that difference has significance,It is judged as that difference has pole significance.
Result
3.1 Compositionss 6 Impact to the hypogalactia dams lactation amount of levodopaThe results are shown in Table 1.Compared with blank group rat, model group rats the 4th, 7,10 days 8h lactation amounts after childbirth significantly reduce.Compare with model control group, the basic, normal, high dosage group rat of compositionss 6 the 4th, 7,10 days 8h lactation amounts after childbirth substantially increase.Prompting combination thing 6 can increase the hypogalactia dams lactation amount of levodopa.
3.2 Compositionss 6 Impact to filial mice body weightThe results are shown in Table 2.Compared with blank group rat, model group filial mice the 4th, 7,10 days weight gain after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group filial mice of compositionss 6 the 4th, 7,10 days weight gain after childbirth substantially increase.Prompting combination thing 6 can promote filial mice body weight increase.
Compositionss 6 Impact to rat prolactin secretion age of sucking The results are shown in Table 3.Compared with blank group rat, model group dams the 4th, 7,10 days Serum Prolactin In Patients after childbirth are decreased obviously.Compare with model control group, the basic, normal, high dosage group dams of compositionss 6 the 4th, 7,10 days Serum Prolactin In Patients after childbirth substantially increase.Prompting combination thing 6 can increase the secretion of dams lactotropin.
Conclusion :
Animal experiment study shows：Compositionss 6 can increase the hypogalactia dams lactation amount of levodopa, promotes filial mice body weight increase, increases the secretion of dams lactotropin, and prompting combination thing 6 plays the role of lactogenic.
The lactogenic extract of the present invention, can be raw material water extraction and/or ethanol extract, or the water extraction of one or more of raw material and/or ethanol extract；Described alcohol is methanol or ethanol, methanol concentration 5 95%, and concentration of alcohol is 5 95%.
The water of raw material of lactogenic extract of the present invention and/or the preparation technology of alcohol extracting thing, comprise the following steps：
1) traditional Chinese medicinal material raw materials are weighed by recipe quantity；
2) water being 5～95% methanol or ethanol or 6～15 times amount with concentration, to above-mentioned medicinal material extract, obtains extracting solution and does active ingredient.
The preparation technology of the extract of the raw material of compositionss of the present invention, raw water and/or alcohol extracting thing is it is also possible to press step preparation：
1）Weigh raw material by recipe quantity, raw medicinal material plus 5～95% methanol or ethanol extracted, and extracting solution reclaims methanol or ethanol, obtains extract I；
2）Above-mentioned medicinal residues are volatilized after alcohol, plus 6～water of 15 times amount extracted, and obtains extract II；
3）United extraction thing I and extract II, filter, filtrate is concentrated in right amount, obtains extracting solution and does active ingredient.
The preparation method of inventive formulation milk product, comprises the following steps：
1st, the tellurium foot of raw material Ungula Sus domestica or Ungula Sus domestica or the idol tellurium class animal such as poker or cattle tellurium is carried out pre-treatment, pulverize or liming or extract, concentrate, refined.
2 or by Radix hemerocalis plicatae water extraction, concentration, it is dried.
3 or by Semen sojae atricolor, water soaks, and pulverizes making beating, filters, obtains serosity；Or Semen sojae atricolor bakees processing with low temperature, micronizing grinds to form Semen sojae atricolor powder.
4 or Carassius auratuss are cleaned, after chopping, suitable quantity of water, heating simmers, and all materials in pot are broken into juice, and after filtration, taking juice is standby or dries, and pulverizing is standby.
5th, by raw milk, only breast, cold preservation, batch mixing, homogenizing, sterilization, concentration, spray drying, sieve powder, dry in the air powder.
Preferably the following step：
1st, Ungula Sus domestica pre-treatment or 2-10 times amount saturated limewater solution liming, 1-15 times amount alkali liquor are extracted, the preferred 2h-18h of extraction time scope；Or 1-15 times amount water extraction, Ungula Sus domestica water extraction time 0.2h-18h, or alkali carries extracting solution and water extraction extracting solution are merged, concentration, activated carbon adsorption, refined, fill.
2 or Radix hemerocalis plicatae extracting in water 2-3 time, each amount of water 6-30 times amount, each extraction time 0.5-4h, united extraction liquid, concentrate, be spray-dried.
3 or by Semen sojae atricolor, 20-40 DEG C of water soaks 0.20-8h, pulverizes making beating, and 100-300 mesh filters, and obtains serosity, is dried；Or Semen sojae atricolor is bakeed with 50-70 DEG C of low temperature, the baking time is 4.5-6.5h, and micronizing grinds to form the Semen sojae atricolor powder that granularity is 100-350 mesh.
4 or Carassius auratuss are cleaned, after chopping, plus 2-10 times of water, heating simmers 35-55 minute, all materials in pot is broken into juice, after filtration, taking juice, and dry, pulverizing.
5th, Medulla Tetrapanacis adds 5-40 times of decocting to boil, and boils 0.2-4h, extracts 1-4 time, takes filtrate, and standing is concentrated into density after taking supernatant be 1.0 1 1.3；Concentrated extracting solution；The extracting solution having concentrated is spray-dried, powder is crossed mesh sieve, made extract；
Further preferably the following step：
1st, Ungula Sus domestica pre-treatment or 3-6 times amount saturated limewater solution liming, the extraction of 2-10 times amount alkali liquor, Ungula Sus domestica alkali carries time 4h-14h；Can also 2-10 times amount water extraction, Ungula Sus domestica water extraction time 1h-14h, or alkali carries extracting solution and water extraction extracting solution are merged, concentrations, activated carbon adsorption, refine, fill.
2 or by Radix hemerocalis plicatae extracting in water 2-3 time, each amount of water 10-20 times amount, each extraction time 1-2h, united extraction liquid, it is spray-dried.
3 or by Semen sojae atricolor, 25-35 DEG C of water soaks 1-4 h, pulverizes making beating, and 120-200 mesh filters, and obtains serosity, is dried；Or Semen sojae atricolor is bakeed with 55-65 DEG C of low temperature, the baking time is 5-6h, and micronizing grinds to form the Semen sojae atricolor powder that granularity is 150 mesh.
4 or Carassius auratuss are cleaned, after chopping, plus 5-8 times of water, simmer 40-50 minute, all materials in pot are broken into juice, after filtration, taking juice, dry, pulverizing.
5 or Medulla Tetrapanacis boiled with 30 times of decoctings, extract 3 times, each boiling time 1h, filter out extracting solution；Concentrated extracting solution, the extracting solution having concentrated is spray-dried, and inlet temperature is 70 DEG C, and charging rate is 25ml/ minute, and 90 mesh sieves obtain Medulla Tetrapanacis extract.
The milk product formula that the present invention provides, adds the extract of natural high-quality animal-plant material, makes wet nurse secrete more milk；Add in described formula prebioticses (GOS, FOS) to suckling mother's intestine moistening, allow wet nurse's intestinal health, add DHA, promote baby's brain and skeleton development.
Specific embodiment
Embodiment 1：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 1.5%；Docosahexenoic acid (DHA) powder 2%；
Conjugated linoleic acid glyceride 3%；Oligomeric galactose（GOS）3%；Oligofructose（FOS）0.33%；Milk powder 50%；Lactalbumin 3%；Lactose 3%；Vitamin 0.5%；Mineral 1.7%；Described lactogenic extract is Ungula Sus domestica extract.Use Ungula Sus domestica 10Kg, 90 DEG C of Ungula Sus domestica 1 times amount aqueous are extracted 2 times, extracting solution is merged by water extraction time 2h, concentrates, obtains Ungula Sus domestica extract；Then Ungula Sus domestica extract is prepared according to the above ratio with each raw material, after packaging, obtain finished product.
Embodiment 2：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 3%；Docosahexenoic acid (DHA) powder 5%；
Conjugated linoleic acid glyceride 6%；Oligomeric galactose（GOS）6%；Oligofructose（FOS）0.67%；Be equivalent to the lactogenesis 85% of equivalent milk powder；Lactalbumin 20%；Lactose 6%；Vitamin 0.7%；Mineral 2%；Described lactogenic extract is Ungula Sus domestica extract.Take Ungula Sus domestica 500Kg, the water extraction of 15 times amount 3 times, water extraction time 18h, Aqueous extracts are merged, concentrate, refine, Ungula Sus domestica extract；Raw milk, only breast, cold preservation；Then by Ungula Sus domestica extract and lactogenesis batch mixing, homogenizing, sterilization, concentration, spray drying, sieve powder, the powder that dries in the air, again with aforementioned proportion preparation of raw material, after packaging finished product.
Embodiment 3：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is Ungula Sus domestica extract.Use Ungula Sus domestica 10Kg, extracted 2 times with 90 DEG C of the water of 1 times amount, water extraction time 2h, Aqueous extracts are merged, concentrate, obtain Ungula Sus domestica extract；Then Ungula Sus domestica extract is prepared according to the above ratio with other raw materials, after packaging, obtain finished product.
Embodiment 4：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.5%；Docosahexenoic acid (DHA) powder
4%；Conjugated linoleic acid glyceride 5%；Oligomeric galactose（GOS）5%；Oligofructose（FOS）0.6%；Milk powder 80%；Lactalbumin 15%；Lactose 5%；Vitamin 0.65%；Mineral 1.9%；Described lactogenic extract is Radix Rumicis Japonici extract.Take Radix Rumicis Japonici 10Kg, with 2 times amount saturated limewater solution limings, 1 times amount alkali liquor extraction, extraction time 2h；The water extraction of 1 times amount, extraction time 2h, alkali extract and Aqueous extracts are merged, concentrations, activated carbon adsorption, refines, obtain Radix Rumicis Japonici extract；Then Radix Rumicis Japonici extract and other raw material are prepared according to the above ratio, obtain finished product after packaging.
Embodiment 5：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.25%；Docosahexenoic acid (DHA) powder 3.5%；Conjugated linoleic acid glyceride 4.3%；Oligomeric galactose（GOS）4.5%；Oligofructose（FOS） 0.5%；Milk powder 70%；Lactalbumin（Concentrated lactoalbumin, whey powder）10%；Lactose 4.5%；Vitamin 0.6%；Mineral 1.85%；Described lactogenic extract is Ungula Sus domestica extract.Take Ungula Sus domestica 10Kg, extracted 2 times with 90 DEG C of the water of 1 times amount, extraction time 2h, Aqueous extracts are merged, concentrate, obtain Ungula Sus domestica extract；Then Ungula Sus domestica extract is prepared according to the above ratio with each raw material, after packaging, obtain finished product.
Embodiment 6：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 1.5%；Docosahexenoic acid (DHA) powder 2%；Conjugated linoleic acid glyceride 3%；Oligomeric galactose（GOS）3%；Oligofructose（FOS）0.33%；Milk powder 50%；Lactalbumin 3%；Lactose 3%；Vitamin 0.5%；Mineral 1.7%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 30%；Radix hemerocalis plicatae 70%.Ungula Sus domestica 2 times amount saturated limewater solution liming, 1 times amount alkali liquor extract, extraction time 2h；1 times amount aqueous are extracted, extraction time 2h, and alkali extract and Aqueous extracts are merged, and concentrations, activated carbon adsorption, refine, and obtain Ungula Sus domestica extract；By Radix hemerocalis plicatae extracting in water 2 times, each amount of water 10 times amount, each extraction time 1h, united extraction liquid, it is spray-dried to obtain Radix hemerocalis plicatae extract；Then with raw material milk powder batch mixing, homogenizing, sterilization, concentration, spray drying, sieve powder, dry in the air powder, prepare according to the above ratio, after packaging finished product.
Embodiment 7：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 3%；Docosahexenoic acid (DHA) powder 5%；Conjugated linoleic acid glyceride 6%；Oligomeric galactose（GOS）6%；Oligofructose（FOS）0.67%；Milk powder 85%；Lactalbumin 20%；Lactose 6%；Vitamin 0.7%；Mineral 2%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 95%；Radix hemerocalis plicatae 5%.The Ungula Sus domestica water extraction 3 times of 14 times amount, extraction time 17h, Aqueous extracts are merged, concentrate, Ungula Sus domestica extract；Radix hemerocalis plicatae extracting in water 3 times, each amount of water 30 times amount, each extraction time 4h, united extraction liquid, concentrate, be spray-dried；Then by Ungula Sus domestica extract, Radix hemerocalis plicatae extract, docosahexenoic acid (DHA) powder；Conjugated linoleic acid glyceride；Oligomeric galactose（GOS）；Oligofructose（FOS）；Milk powder；Lactalbumin；Lactose；Vitamin；Mineral；It is made into finished product according to the above ratio.
Embodiment 8：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 15%；Radix hemerocalis plicatae 85%.The Ungula Sus domestica water extraction 3 times of 12 times amount, extraction time 10h, Aqueous extracts are merged, concentrates, become Ungula Sus domestica extract；Radix hemerocalis plicatae extracting in water 3 times, each amount of water 30 times amount, each extraction time 4h, united extraction liquid, concentrate, be spray-dried；Then by Ungula Sus domestica extract, Radix hemerocalis plicatae extract, docosahexenoic acid (DHA) powder；Conjugated linoleic acid glyceride；Oligomeric galactose（GOS）；Oligofructose（FOS）；Milk powder；Lactalbumin；Lactose；Vitamin；Mineral；It is made into finished product according to the above ratio.
Embodiment 9：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.5%；Docosahexenoic acid (DHA) powder 4%；Conjugated linoleic acid glyceride 5%；Oligomeric galactose（GOS）5%；Oligofructose（FOS）0.6%；Milk powder 80%；Lactalbumin 15%；Lactose 5%；Vitamin 0.65%；Mineral 1.9%；Described lactogenic extract is by weight percentage：Radix Rumicis Japonici 90%；Radix hemerocalis plicatae 10%.The Radix Rumicis Japonici water extraction 3 times of 12 times amount, extraction time 10h, Aqueous extracts are merged, concentrates, become Radix Rumicis Japonici extract；Radix hemerocalis plicatae extracting in water 3 times, each amount of water 30 times amount, each extraction time 4h, united extraction liquid, concentrate, be spray-dried；Then by Radix Rumicis Japonici extract, Radix hemerocalis plicatae extract, docosahexenoic acid (DHA) powder；Conjugated linoleic acid glyceride；Oligomeric galactose（GOS）；Oligofructose（FOS）；Milk powder；Lactalbumin；Lactose；Vitamin；Mineral；It is made into finished product according to the above ratio.
Embodiment 10：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.25%；Docosahexenoic acid (DHA) powder 3.5%；Conjugated linoleic acid glyceride 4.3%；Oligomeric galactose（GOS）4.5%；Oligofructose（FOS） 0.5%；Milk powder 68%；Lactalbumin（Concentrated lactoalbumin, whey powder）8%；Lactose 4.5%；Vitamin 0.6%；Mineral 1.85%；Described lactogenic extract is：Ungula Sus domestica 50%；Radix hemerocalis plicatae 50%.Take Ungula Sus domestica 50Kg；Radix hemerocalis plicatae 50Kg.Preparation method is with embodiment 8.
Embodiment 11：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 1.5%；Docosahexenoic acid (DHA) powder 2%；Conjugated linoleic acid glyceride 3%；Oligomeric galactose（GOS）3%；Oligofructose（FOS）0.33%；Milk powder 50%；Lactalbumin 3%；Lactose 3%；Vitamin 0.5%；Mineral 1.7%；Described lactogenic extract Radix hemerocalis plicatae extract.Radix hemerocalis plicatae extracting in water 2 times, each amount of water 10 times amount, each extraction time 1h, united extraction liquid, it is spray-dried to obtain Radix hemerocalis plicatae extract；Then according to the above ratio with each preparation of raw material, after packaging finished product.
Embodiment 12：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 3%；Docosahexenoic acid (DHA) powder 5%；Conjugated linoleic acid glyceride 6%；Oligomeric galactose（GOS）6%；Oligofructose（FOS）0.67%；Milk powder 85%；Lactalbumin 20%；Lactose 6%；Vitamin 0.7%；Mineral 2%；Described lactogenic extract Radix hemerocalis plicatae extract.Radix hemerocalis plicatae extracting in water 2 times, each amount of water 10 times amount, each extraction time 1h, united extraction liquid, it is spray-dried to obtain Radix hemerocalis plicatae extract；Then according to the above ratio with each preparation of raw material, after packaging finished product.
Embodiment 13：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is Radix hemerocalis plicatae extract.Preparation method is with embodiment 8.
Embodiment 14：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.5%；Docosahexenoic acid (DHA) powder 4%；Conjugated linoleic acid glyceride 5%；Oligomeric galactose（GOS）5%；Oligofructose（FOS）0.6%；Milk powder 80%；Lactalbumin 15%；Lactose 5%；Vitamin 0.65%；Mineral 1.9%；Described lactogenic extract is Radix hemerocalis plicatae extract.Preparation method is with embodiment 8.
Embodiment 15：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.25%；Docosahexenoic acid (DHA) powder 3.5%；Conjugated linoleic acid glyceride 4.3%；Oligomeric galactose（GOS）4.5%；Oligofructose（FOS） 0.5%；Milk powder 68～70%；Lactalbumin（Concentrated lactoalbumin, whey powder）10%；Lactose 4.5%；Vitamin 0.6%；Mineral 1.85%；Described lactogenic extract is Radix hemerocalis plicatae extract.Preparation method is with embodiment 8.
Embodiment 16：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 1.5%；Docosahexenoic acid (DHA) powder 2%；Conjugated linoleic acid glyceride 3%；Oligomeric galactose（GOS）3%；Oligofructose（FOS）0.33%；Milk powder 50%；Lactalbumin 3%；Lactose 3%；Vitamin 0.5%；Mineral 1.7%；Described lactogenic extract is Medulla Tetrapanacis extract.Medulla Tetrapanacis extracting in water 3 times, each amount of water 30 times amount, each extraction time 1h, united extraction liquid, it is spray-dried to obtain Medulla Tetrapanacis extract；Then with raw material milk powder batch mixing, homogenizing, sterilization, sieve powder, dry in the air powder, each raw material is prepared according to the above ratio, after packaging finished product.
Embodiment 17：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 3%；Docosahexenoic acid (DHA) powder 5%；Conjugated linoleic acid glyceride 6%；Oligomeric galactose（GOS）6%；Oligofructose（FOS）0.67%；Milk powder 85%；Lactalbumin 20%；Lactose 6%；Vitamin 0.7%；Mineral 2%；Described lactogenic extract is Medulla Tetrapanacis extract.Preparation method is with embodiment 16.
Embodiment 18：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS） 4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is Medulla Tetrapanacis extract.Preparation method is with embodiment 16.
Embodiment 19：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.5%；Docosahexenoic acid (DHA) powder 4%；Conjugated linoleic acid glyceride 5%；Oligomeric galactose（GOS5%；Oligofructose（FOS）0.6%；Milk powder 80%；Lactalbumin 15%；Lactose 5%；Vitamin 0.65%；Mineral 1.9%；Described lactogenic extract is Medulla Tetrapanacis extract.Preparation method is with embodiment 16.
Embodiment 20：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.25%；Docosahexenoic acid (DHA) powder 3.5%；Conjugated linoleic acid glyceride 4.3%；Oligomeric galactose（GOS）4.5%；Oligofructose（FOS）0.5%；Milk powder 69%；Lactalbumin（Concentrated lactoalbumin, whey powder）9%；Lactose 4.5%；Vitamin 0.6%；Mineral 1.85%；Described lactogenic extract is Medulla Tetrapanacis extract.Preparation method is with embodiment 16.
Embodiment 21：
A kind of milk product, by weight percentage, containing following composition：Lactogenic extract 1.5%；Docosahexenoic acid (DHA) powder 2%；Conjugated linoleic acid glyceride 3%；Oligomeric galactose（GOS）3%；Oligofructose（FOS）0.33%；Milk powder 50%；Lactalbumin 3%；Lactose 3%；Vitamin 0.5%；Mineral 1.7%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 3%；Radix hemerocalis plicatae 70%；Semen sojae atricolor 27%.Ungula Sus domestica 4 times of amount water extraction 2 times, extraction time 3h, Aqueous extracts are merged, concentrate, are refining to obtain Ungula Sus domestica extract；Radix hemerocalis plicatae extracting in water 2 times, each amount of water 6 times amount, each extraction time 0.5h, united extraction liquid, concentrate, be spray-dried, obtain Radix hemerocalis plicatae extract；The water that 20 DEG C of Semen sojae atricolor soaks 2h, pulverizes making beating, and 100 mesh filter, and obtain serosity, are dried, obtain soybean extract；Then obtain finished product by after Ungula Sus domestica extract, Radix hemerocalis plicatae extract, Semen sojae atricolor powder and each mixing raw materials, sterilization, packaging.
Embodiment 22：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 3%；Docosahexenoic acid (DHA) powder 5%；Conjugated linoleic acid glyceride 6%；Oligomeric galactose（GOS）6%；Oligofructose（FOS）0.67%；Milk powder 85%；Lactalbumin 20%；Lactose 6%；Vitamin 0.7%；Mineral 2%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 95%；Radix hemerocalis plicatae 2%；Semen sojae atricolor 3%.Preparation method is with embodiment 21.
Embodiment 23：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）4%；Milk powder or the raw milk 55% being equivalent to equivalent milk powder；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 10%；Radix hemerocalis plicatae 60%, Semen sojae atricolor 30%.Ungula Sus domestica 4 times of amount water extraction 2 times, extraction time 3h, Aqueous extracts are merged, concentrate, are refining to obtain Ungula Sus domestica extract；Radix hemerocalis plicatae extracting in water 2 times, each amount of water 6 times amount, each extraction time 0.5h, united extraction liquid, concentrate, be spray-dried, obtain Radix hemerocalis plicatae extract；The water that 20 DEG C of Semen sojae atricolor soaks 2h, pulverizes making beating, and 100 mesh filter, and obtain serosity, are dried, obtain soybean extract；Raw milk, only breast, cold preservation, homogenizing, concentration, spray drying；Then obtain finished product by after Ungula Sus domestica extract, Radix hemerocalis plicatae extract, Semen sojae atricolor powder and each mixing raw materials, sterilization, packaging.
Embodiment 24：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.5%；Docosahexenoic acid (DHA) powder 4%；Conjugated linoleic acid glyceride 5%；Oligomeric galactose（GOS）5%；Oligofructose（FOS）0.6%；Milk powder 80%；Lactalbumin 15%；Lactose 5%；Vitamin 0.65%；Mineral 1.9%；Described lactogenic extract is by weight percentage：Radix Rumicis Japonici 65%；Radix hemerocalis plicatae 25%, Semen sojae atricolor 10%.Preparation method is with embodiment 21.
Embodiment 25：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.25%；Docosahexenoic acid (DHA) powder 3.5%；Conjugated linoleic acid glyceride 4.3%；Oligomeric galactose（GOS）4.5%；Oligofructose（FOS）0.5%；Milk powder 70%；Lactalbumin 10%；Lactose 4.5%；Vitamin 0.6%；Mineral 1.85%；Described lactogenic extract is：Ungula Sus domestica 40%；Radix hemerocalis plicatae 30%, Semen sojae atricolor 30%.Take Ungula Sus domestica 40Kg；Radix hemerocalis plicatae 30Kg；Semen sojae atricolor 30Kg.Preparation method is with embodiment 21.
Embodiment 26
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 1.5%；Docosahexenoic acid (DHA) powder 2%；Conjugated linoleic acid glyceride 3%；Oligomeric galactose（GOS）3%；Oligofructose（FOS）0.33%；Milk powder or the raw Lac caprae seu ovis 50% being equivalent to equivalent milk powder；Lactalbumin 3%；Lactose 3%；Vitamin 0.5%；Mineral 1.7%；Described lactogenic extract is soybean extract.The water that 35 DEG C of Semen sojae atricolor soaks 4 h, pulverizes making beating, and 200 mesh filter, and obtain serosity, dry Semen sojae atricolor powder；Raw material Lac caprae seu ovis, only breast, cold preservation；Then by each raw material and soybean extract add Lac caprae seu ovis batch mixing, homogenizing, sterilization, concentration, spray drying, sieve powder, the powder that dries in the air, after packaging finished product.
Embodiment 27
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 3%；Docosahexenoic acid (DHA) powder 5%；Conjugated linoleic acid glyceride 6%；Oligomeric galactose（GOS）6%；Oligofructose（FOS）0.67%；Milk powder or the lactogenesis 85% being equivalent to equivalent milk powder；Lactalbumin 20%；Lactose 6%；Vitamin 0.7%；Mineral 2%；Described lactogenic extract is soybean extract.Preparation method is with embodiment 26.
Embodiment 28
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is soybean extract.The water that 30 DEG C of Semen sojae atricolor soaks 6 h, pulverizes making beating, and 200 mesh filter, and obtain serosity, dry Semen sojae atricolor powder；Then obtain finished product by after Semen sojae atricolor powder and each mixing raw materials, sterilization, packaging.
Embodiment 29
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.5%；Docosahexenoic acid (DHA) powder 4%；Conjugated linoleic acid glyceride 5%；Oligomeric galactose（GOS）5%；Oligofructose（FOS）0.6%；Milk powder 80%；Lactalbumin 15%；Lactose 5%；Vitamin 0.65%；Mineral 1.9%；Described lactogenic extract is soybean extract.Preparation method is with embodiment 28.
Embodiment 30
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.25%；Docosahexenoic acid (DHA) powder 3.5%；Conjugated linoleic acid glyceride 4.3%；Oligomeric galactose（GOS）4.5%；Oligofructose（FOS）0.5%；Milk powder 68%；Lactalbumin（Concentrated lactoalbumin, whey powder）8%；Lactose 4.5%；Vitamin 0.6%；Mineral 1.85%；Described lactogenic extract is soybean extract.Preparation method is with embodiment 28.
Embodiment 31
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 1.5%；Docosahexenoic acid (DHA) powder 2%；Conjugated linoleic acid glyceride 3%；Oligomeric galactose（GOS）3%；Oligofructose（FOS）0.33%；Milk powder 50%；Lactalbumin 3%；Lactose 3%；Vitamin 0.5%；Mineral 1.7%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 2%；Medulla Tetrapanacis 98%.The Ungula Sus domestica water extraction 3 times of 15 times amount, extraction time 18h, Aqueous extracts are merged, concentrates, refined, Ungula Sus domestica extract；Medulla Tetrapanacis extracting in water 3 times, each amount of water 30 times amount, each extraction time 1h, united extraction liquid, it is spray-dried to obtain Medulla Tetrapanacis extract；Then Ungula Sus domestica extract, Medulla Tetrapanacis extract and other each raw material are prepared according to the above ratio, after packaging, obtain finished product.
Embodiment 32
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 3%；Docosahexenoic acid (DHA) powder 5%；Conjugated linoleic acid glyceride 6%；Oligomeric galactose（GOS）6%；Oligofructose（FOS）0.67%；Milk powder 85%；Lactalbumin 20%；Lactose 6%；Vitamin 0.7%；Mineral 2%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 90%；Medulla Tetrapanacis 10%.
Take Ungula Sus domestica 90 Kg；Medulla Tetrapanacis 10Kg.Preparation method is with embodiment 31.
Embodiment 33
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 15%；Medulla Tetrapanacis 85%.Take Ungula Sus domestica 15Kg；Medulla Tetrapanacis 85Kg.Preparation method is with embodiment 31.
Embodiment 34
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.5%；Docosahexenoic acid (DHA) powder 4%；Conjugated linoleic acid glyceride 5%；Oligomeric galactose（GOS）5%；Oligofructose（FOS）0.6%；Milk powder 80%；Lactalbumin 15%；Lactose 5%；Vitamin 0.65%；Mineral 1.9%；Described lactogenic extract is Ungula Sus domestica 50% by weight percentage；Medulla Tetrapanacis 50%.Preparation method is with embodiment 31.
Embodiment 35
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.25%；Docosahexenoic acid (DHA) powder 3.5%；Conjugated linoleic acid glyceride 4.3%；Oligomeric galactose（GOS）4.5%；Oligofructose（FOS）0.5%；Milk powder 70%；Lactalbumin（Concentrated lactoalbumin, whey powder）10%；Lactose 4.5%；Vitamin 0.6%；Mineral 1.85%；Described lactogenic extract is：Ungula Sus domestica 70%；Medulla Tetrapanacis 30%.Preparation method is with embodiment 31.
Embodiment 36
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.25%；Docosahexenoic acid (DHA) powder 3.5%；Conjugated linoleic acid glyceride 4.3%；Oligomeric galactose（GOS）4.5%；Oligofructose（FOS）0.5%；Milk powder 70%；Lactalbumin（Concentrated lactoalbumin, whey powder）10%；Lactose 4.5%；Vitamin 0.6%；Mineral 1.85%；Described lactogenic extract is：Ungula Sus domestica 70%；Retinervus Luffae Fructuss 30%.Preparation method is with embodiment 31.
Embodiment 37
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.25%；Docosahexenoic acid (DHA) powder 3.5%；Conjugated linoleic acid glyceride 4.3%；Oligomeric galactose（GOS）4.5%；Oligofructose（FOS）0.5%；Milk powder 70%；Lactalbumin（Concentrated lactoalbumin, whey powder）10%；Lactose 4.5%；Vitamin 0.6%；Mineral 1.85%；Described lactogenic extract is：Ungula Sus domestica 70%；Fructus Chaenomeliss 30%.The Ungula Sus domestica water extraction 2 times of 3 times amount, water extraction time 5h, Aqueous extracts merge, and obtain Ungula Sus domestica extract；Fructus Chaenomeliss break into juice, filter, concentrate, be spray dried to papaya powder；Then Ungula Sus domestica extract, papaya powder and other each raw material are prepared according to the above ratio, after packaging, obtain finished product.
Embodiment 38
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 15%；Stigma Maydis 85%.Preparation method is with embodiment 31.
Embodiment 39
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 15%；Semen arachidis hypogaeae 85%.Take Ungula Sus domestica 15Kg；Semen arachidis hypogaeae 85Kg.Preparation method is with embodiment 37.
Embodiment 40
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 15%；Fructus Liquidambaris 85%.Preparation method is with embodiment 31.
Embodiment 41
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is by weight percentage：Carassius auratuss 15%；Fructus Liquidambaris 85%.Carassius auratuss are cleaned, after chopping, plus 5 times of water, heating simmers 45 minutes, and all materials in pot are broken into juice, after filtration, taking juice, and obtain Carassius auratuss extract；By Fructus Liquidambaris extracting in water 3 times, each amount of water 20 times amount, each extraction time 1h, united extraction liquid, it is spray-dried to obtain Fructus Lipuidambaris extract；Then by Carassius auratuss extract, Fructus Lipuidambaris extract and each raw material according to the above ratio batch mixing, homogenizing, sterilization, concentration, spray drying, sieve powder, dry in the air powder, after packaging finished product.
Embodiment 42
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is by weight percentage：Cyprinus carpio 15%；Fructus Liquidambaris 85%.Preparation method is with embodiment 41.
Embodiment 43
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2%；Docosahexenoic acid (DHA) powder 3%；Conjugated linoleic acid glyceride 4%；Oligomeric galactose（GOS）4%；Oligofructose（FOS）0.4%；Milk powder 55%；Lactalbumin 5%；Lactose 4%；Vitamin 0.55%；Mineral 1.8%；Described lactogenic extract is by weight percentage：Squama Maniss 15%；Fructus Liquidambaris 85%.Preparation method is with embodiment 31.
Embodiment 44：
A kind of milk product, by weight percentage, containing following composition：Lactogenic extract 1.5%；Docosahexenoic acid (DHA) powder 2%；Conjugated linoleic acid glyceride 3%；Oligomeric galactose（GOS）3%；Oligofructose（FOS）0.33%；Milk powder 50%；Lactalbumin 3%；Lactose 3%；Vitamin 0.5%；Mineral 1.7%；Described lactogenic extract is by weight percentage：Ungula Sus domestica 15%；Semen sojae atricolor 85%.Ungula Sus domestica 4 times of amount water extraction 2 times, extraction time 3h, Aqueous extracts are merged, concentrate, are refining to obtain Ungula Sus domestica extract；The water that 20 DEG C of Semen sojae atricolor soaks 8h, pulverizes making beating, and 100 mesh filter, and obtain serosity, are dried, obtain soybean extract；Then obtain finished product by after Ungula Sus domestica extract, Semen sojae atricolor powder and each mixing raw materials, sterilization, packaging.
Embodiment 45：
Milk product of the present invention, by weight percentage, containing following composition：Lactogenic extract 2.25%；Docosahexenoic acid (DHA) powder 3.5%；Conjugated linoleic acid glyceride 4.3%；Oligomeric galactose（GOS）4.5%；Oligofructose（FOS）0.5%；Milk powder 70%；Lactalbumin 10%；Lactose 4.5%；Vitamin 0.6%；Mineral 1.85%；Described lactogenic extract is：Ungula Sus domestica 50%；Semen sojae atricolor 50%.Take Ungula Sus domestica 40Kg；Radix hemerocalis plicatae 30Kg；Semen sojae atricolor 30Kg.

Claims (33)

1. a kind of milk product, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
It is characterized in that：Described lactogenic extract includes by weight percentage：One of Ungula Sus domestica or Radix Rumicis Japonici 2～100%, Carassius auratuss 2～100%, Cyprinus carpio 2～100%, Trichiurus haumela 2～100%, Squama Maniss 2～100%, Radix hemerocalis plicatae 2～100%, Semen sojae atricolor 2～100%, Medulla Tetrapanacis 2～100%, Retinervus Luffae Fructuss 2～100%, Fructus Chaenomeliss 2～100%, Semen arachidis hypogaeae 2～100%, Caulis Akebiae 2～100%, Fructus Liquidambaris 2～100%, Stigma Maydis 2～100% or combination in any.
2. milk product according to claim 1, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract includes by weight percentage：One of Ungula Sus domestica or Radix Rumicis Japonici 15～90%, Carassius auratuss 15～90%, Cyprinus carpio 15～90%, Trichiurus haumela 15～90%, Squama Maniss 15～90%, Radix hemerocalis plicatae 10～85%, Semen sojae atricolor 10～85%, Caulis Akebiae 10～85%, Medulla Tetrapanacis 10～85%, Retinervus Luffae Fructuss 10～85%, Fructus Chaenomeliss 10～85%, Semen arachidis hypogaeae 10～85%, Fructus Liquidambaris 10～85%, Stigma Maydis 10～85% or combination in any.
3. milk product according to claim 2, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid powder 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract includes：One of Ungula Sus domestica or Radix Rumicis Japonici 50%, Carassius auratuss 50%, Cyprinus carpio 50%, Trichiurus haumela 50%, Squama Maniss 50%, Radix hemerocalis plicatae 50%, Semen sojae atricolor 50%, Medulla Tetrapanacis 50%, Retinervus Luffae Fructuss 50%, Fructus Chaenomeliss 50%, Semen arachidis hypogaeae 50%, Caulis Akebiae 50%, Fructus Liquidambaris 50%, Stigma Maydis 50% or combination in any.
4. milk product according to claim 1, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is the extract of Ungula Sus domestica or Radix Rumicis Japonici.
5. milk product according to claim 4, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is Ungula Sus domestica or Radix Rumicis Japonici extract.
6. milk product according to claim 5, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is Ungula Sus domestica or Radix Rumicis Japonici extract.
7. milk product according to claim 1, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 2～95%；Radix hemerocalis plicatae 5～98%.
8. milk product according to claim 7, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 15～90%；Radix hemerocalis plicatae 10～85%.
9. milk product according to claim 8, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is：Ungula Sus domestica or Radix Rumicis Japonici 50%；Radix hemerocalis plicatae 50%.
10. milk product according to claim 1, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is Radix hemerocalis plicatae extract.
11. milk product according to claim 10, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid (DHA) powder 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose（GOS） 4～5%；
Oligofructose（FOS） 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is Radix hemerocalis plicatae extract.
12. milk product according to claim 11, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is Radix hemerocalis plicatae extract.
13. milk product according to claim 1, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is Medulla Tetrapanacis extract.
14. milk product according to claim 13, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is Medulla Tetrapanacis extract.
15. milk product according to claim 14, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid powder 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is Medulla Tetrapanacis extract.
16. milk product according to claim 1, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 3～95%；Radix hemerocalis plicatae 2～70%；Semen sojae atricolor 3～70%.
17. milk product according to claim 16, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 10～65%；Radix hemerocalis plicatae 8～60%；Semen sojae atricolor 8～60%.
18. milk product according to claim 17, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is：Ungula Sus domestica or Radix Rumicis Japonici 40%；Radix hemerocalis plicatae 30%；Semen sojae atricolor 30%.
19. milk product according to claim 1, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 2～95%；Semen sojae atricolor 5～98%.
20. milk product according to claim 19, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 15～90%；Semen sojae atricolor 10～85%.
21. milk product according to claim 20, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose 4.5%；
Oligofructose 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin 8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is：Ungula Sus domestica or Radix Rumicis Japonici 50%；Semen sojae atricolor 50%.
22. milk product according to claim 1, by weight percentage, containing following composition：
Lactogenic extract 1.5～3%；
Docosahexenoic acid 2～5%；
Conjugated linoleic acid glyceride 3～6%；
Oligomeric galactose 3～6%；
Oligofructose 0.33～0.67%；
Milk powder or the lactogenesis 50～85% being equivalent to equivalent milk powder；
Lactalbumin 3～20%；
Lactose 3～6%；
Vitamin 0.5～0.7%；
Mineral 1.7～2%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 2～95%；Medulla Tetrapanacis 5～98%.
23. milk product according to claim 22, by weight percentage, containing following composition：
Lactogenic extract 2～2.5%；
Docosahexenoic acid 3～4%；
Conjugated linoleic acid glyceride 4～5%；
Oligomeric galactose 4～5%；
Oligofructose 0.4～0.6%；
Milk powder or the lactogenesis 55～80% being equivalent to equivalent milk powder；
Lactalbumin 5～15%；
Lactose 4～5%；
Vitamin 0.55～0.65%；
Mineral 1.8～1.9%；
Described lactogenic extract is by weight percentage：Ungula Sus domestica or Radix Rumicis Japonici 15～90%；Medulla Tetrapanacis 10～85%.
24. milk product according to claim 23, by weight percentage, containing following composition：
Lactogenic extract 2.25%；
Docosahexenoic acid (DHA) powder 3.5%；
Conjugated linoleic acid glyceride 4.3%；
Oligomeric galactose（GOS）4.5%；
Oligofructose（FOS） 0.5%；
The lactogenesis 68～70% of milk powder or equivalent milk powder；
Lactalbumin（Concentrated lactoalbumin, whey powder）8～10%；
Lactose 4.5%；
Vitamin 0.6%；
Mineral 1.85%；
Described lactogenic extract is：Ungula Sus domestica or Radix Rumicis Japonici 50%；Medulla Tetrapanacis 50%.
25. according to the arbitrary described milk product of claim 1-24 it is characterised in that：Vitamin is Vitamin A Acetate, vitamin D3 (cholecalciferol), Vitamin E, vitamin C（Ascorbic acid）, vitamin B1（Thiamine hydrochloride）, vitamin B2（Riboflavin）, vitamin B6（Pyridoxine hydrochloride）, nicotinic acid, pantothenic acid（D-VB5 calcium）, Folic Acid, any one or a combination thereof in vitamin B12.
26. according to the arbitrary described milk product of claim 1-24 it is characterised in that：Mineral is Calcium Carbonate, calcium phosphate, ferrous sulfate, ferric phrophosphate, ferric ammonium citrate, magnesium sulfate, zinc sulfate, potassium chloride, any one or a combination thereof in taurine.
27. according to the arbitrary described milk product of claim 1-24 it is characterised in that：Described lactogenesis is the normal breast of no any composition change of extrusion in healthy dairy stock breast.
28. according to the arbitrary described milk product of claim 1-24 it is characterised in that：Described milk powder is with raw milk or raw Lac caprae seu ovis as raw material, the processed full-cream or defat made or partially skimmed milk powder or modulation milk powder or cattle colostrums powder.
29. according to the arbitrary described milk product of claim 1-24 it is characterised in that：Raw material Ungula Sus domestica, is replaced with the tellurium foot of poker or cattle tellurium or even tellurium class animal.
30. according to the arbitrary described milk product of claim 1-24 it is characterised in that：Including one of liquid milk, milk powder, Lactose, milk slice or its combination in any.
31. milk product according to claim 30 it is characterised in that：Liquid milk is one of pasteurization milk, sterilized milk, modulation breast, fermentation milk or its combination in any.
32. milk product according to claim 30 it is characterised in that：Milk powder is one of whole milk powder, skimmed milk powder, half skimmed milk powder, modulation milk powder or its combination in any.
Application in preparation lactogenic product for the arbitrary described milk product of 33. claim 1-24.
CN201510554139.5A 2015-09-02 2015-09-02 A kind of milk product Pending CN106472680A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510554139.5A CN106472680A (en) 2015-09-02 2015-09-02 A kind of milk product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510554139.5A CN106472680A (en) 2015-09-02 2015-09-02 A kind of milk product

Publications (1)

Publication Number Publication Date
CN106472680A true CN106472680A (en) 2017-03-08

Family

ID=58237692

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510554139.5A Pending CN106472680A (en) 2015-09-02 2015-09-02 A kind of milk product

Country Status (1)

Country Link
CN (1) CN106472680A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109362888A (en) * 2018-10-30 2019-02-22 徐州汇尔康食品有限公司 A kind of puerpera's dairy products that suitable postpartum puerpera eats
CN114271335A (en) * 2021-11-30 2022-04-05 倍恩喜(湖南)乳业有限公司 Dairy product and method for producing the same
CN115039889A (en) * 2022-05-10 2022-09-13 北京大学 Lactoferrin composition and preparation and application thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097136A (en) * 1993-07-05 1995-01-11 湖南益阳光大中药科技开发公司 The puerpera uses lactation-promoting nutrient oral liquor
CN1209962A (en) * 1996-02-07 1999-03-10 广西桂平恒生保健品厂 Murubao instant powder
CN1475228A (en) * 2002-08-14 2004-02-18 周爱桥 Lactation and blood. tonifying oral liquid and its preparation method
CN102497788A (en) * 2009-07-29 2012-06-13 法国婴儿营养实验室 Nutritional composition for lactating women
CN102580007A (en) * 2012-03-23 2012-07-18 常熟市虞山绿茶有限公司 Lactation-promoting and menstruation-inducing Chinese medicinal composition for puerperae
CN103653087A (en) * 2013-11-28 2014-03-26 苏君 Lactation-promoting nutritional soup and preparation method thereof
CN103830502A (en) * 2014-03-26 2014-06-04 蚌埠火鹤制药有限公司 Traditional Chinese medicine composition for lactagogue
CN104800511A (en) * 2015-05-13 2015-07-29 岑溪市坤发液体燃烧炉具有限公司 Traditional Chinese medicine recipe for treating lumbago caused by deficiency of kidney, poor memory and puerpera agalactosis

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097136A (en) * 1993-07-05 1995-01-11 湖南益阳光大中药科技开发公司 The puerpera uses lactation-promoting nutrient oral liquor
CN1209962A (en) * 1996-02-07 1999-03-10 广西桂平恒生保健品厂 Murubao instant powder
CN1475228A (en) * 2002-08-14 2004-02-18 周爱桥 Lactation and blood. tonifying oral liquid and its preparation method
CN102497788A (en) * 2009-07-29 2012-06-13 法国婴儿营养实验室 Nutritional composition for lactating women
CN102580007A (en) * 2012-03-23 2012-07-18 常熟市虞山绿茶有限公司 Lactation-promoting and menstruation-inducing Chinese medicinal composition for puerperae
CN103653087A (en) * 2013-11-28 2014-03-26 苏君 Lactation-promoting nutritional soup and preparation method thereof
CN103830502A (en) * 2014-03-26 2014-06-04 蚌埠火鹤制药有限公司 Traditional Chinese medicine composition for lactagogue
CN104800511A (en) * 2015-05-13 2015-07-29 岑溪市坤发液体燃烧炉具有限公司 Traditional Chinese medicine recipe for treating lumbago caused by deficiency of kidney, poor memory and puerpera agalactosis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
丁丽翔: "《催乳师多媒体教程》", 30 September 2014, 农村读物出版社 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109362888A (en) * 2018-10-30 2019-02-22 徐州汇尔康食品有限公司 A kind of puerpera's dairy products that suitable postpartum puerpera eats
CN114271335A (en) * 2021-11-30 2022-04-05 倍恩喜(湖南)乳业有限公司 Dairy product and method for producing the same
CN115039889A (en) * 2022-05-10 2022-09-13 北京大学 Lactoferrin composition and preparation and application thereof

Similar Documents

Publication Publication Date Title
CN102172269B (en) Hidegelatin fabricated food with beautification function
CN105875781A (en) Traditional Chinese medicine healthcare biscuit and preparation method thereof
CN105695258A (en) Female health wine containing lychee seed saponin
CN103610035A (en) Preparation method for sea cucumber nutritional oral liquid
CN102919450A (en) Cereal leaching solution herbal tea and method for preparing same
CN107822040A (en) A kind of preparation method of rhizoma zingiberis cinnamon health care jelly
CN103610072A (en) Preparation method for blood-sugar-reducing sea cucumber oral liquid
CN106472680A (en) A kind of milk product
CN106472682A (en) A kind of milk product
CN106472684A (en) A kind of milk product
CN102511876B (en) Hawthorn red jujube thick syrup and production process thereof
CN104544084B (en) A kind of health food for diabetics
CN105851729A (en) Liquorice carbonated beverage and preparation method thereof
CN106472681A (en) A kind of milk product
CN113925172A (en) Giant salamander peptide nutritional composition suitable for children
CN106472683A (en) A kind of milk product
CN104814372A (en) Health guiling jelly based on sweet potatoes and preparation method of healthy guiling jelly
CN103610112A (en) Immunity-enhancing sea cucumber oral liquid and application method thereof
CN103610068A (en) Preparation method for blood-fat-reducing sea cucumber oral liquid
CN103610069A (en) Blood-sugar-reducing sea cucumber oral liquid
CN106538691A (en) A kind of milk product
CN103610067A (en) Preparation method for immunity-enhancing sea cucumber oral liquid
CN103610070A (en) Blood-fat-reducing sea cucumber oral liquid and application method thereof
CN103610033A (en) Immunity-enhancing sea cucumber oral liquid
CN103611058A (en) Sea cucumber capsule and application method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20170705

Address after: 330004 Jiangxi city of Nanchang province Wanli District Zhaoxian Road No. 1 River Valley

Applicant after: Jiangxi River Food Technology Co. Ltd.

Address before: 330096 Nanchang high tech Zone, Jiangxi Torch Road, No. 788

Applicant before: Zhong Hongguang

Applicant before: Yi Minzhi

SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170308